From: Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
Men
Women
Oesophageal (adenocarcinoma)
Stomach cardia
Kidney
Gallbladder
Liver
Pancreatic
Colorectal
Prostate cancer
Ovarian
Breast
Endometrial